STAAR Surgical Company STAA
NASDAQ
| 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.06M | 5.21M | -18.31M | 8.88M | -16.81M |
| Total Depreciation and Amortization | 2.39M | 2.11M | 2.01M | 2.00M | 1.98M |
| Total Amortization of Deferred Charges | 949.00K | 104.00K | 409.00K | -- | 147.00K |
| Total Other Non-Cash Items | 10.98M | 13.58M | 11.06M | 22.57M | 2.43M |
| Change in Net Operating Assets | -2.68M | -42.69M | 924.00K | -30.79M | -14.99M |
| Cash from Operations | 19.69M | -21.70M | -3.91M | 2.67M | -27.25M |
| Capital Expenditure | -494.00K | -443.00K | -1.68M | -883.00K | -1.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -872.00K | 2.59M | -17.74M | 6.17M | 26.91M |
| Cash from Investing | -1.37M | 2.15M | -19.42M | 5.28M | 25.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 1.24M | 174.00K | 114.00K | 2.97M | 12.00K |
| Repurchase of Common Stock | -2.74M | -1.87M | -164.00K | -1.98M | -4.55M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.50M | -1.69M | -50.00K | 983.00K | -4.54M |
| Foreign Exchange rate Adjustments | -107.00K | -45.00K | 374.00K | 91.00K | 686.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.72M | -21.29M | -23.01M | 9.02M | -5.98M |